Owosho, A., Tyler, D., Adesina, O., Odujoko, O., & Summersgill, K. (2021). NR4A3 (NOR-1) Immunostaining Shows Better Performance than DOG1 Immunostaining in Acinic Cell Carcinoma of Salivary Gland: A Preliminary Study. J Oral Maxillofac Res.
Chicago Style CitationOwosho, Adepitan, Donald Tyler, Olufunlola Adesina, Oluwole Odujoko, i Kurt Summersgill. "NR4A3 (NOR-1) Immunostaining Shows Better Performance Than DOG1 Immunostaining in Acinic Cell Carcinoma of Salivary Gland: A Preliminary Study." J Oral Maxillofac Res 2021.
Cita MLAOwosho, Adepitan, et al. "NR4A3 (NOR-1) Immunostaining Shows Better Performance Than DOG1 Immunostaining in Acinic Cell Carcinoma of Salivary Gland: A Preliminary Study." J Oral Maxillofac Res 2021.
Atenció: Aquestes cites poden no estar 100% correctes.